Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1

Conditions

Neoplasms 2Multiple Myeloma 2Leukemia, Myeloid, Acute 2Non-Muscle Invasive Bladder Neoplasms 1Neoplasm, Residual 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

venetoclax 26Azacitidine 24fludarabine 11Cytarabine 11Specimen Handling 9Biopsy 7Busulfan 6Melphalan 5Decitabine 5Daunorubicin 5Thiotepa 4Cyclophosphamide 4selinexor 3olutasidenib 3gilteritinib 3Whole-Body Irradiation 3Tacrolimus 3Idarubicin 3Homoharringtonine 3treosulfan 2revumenib 2fludarabine phosphate 2decitabine and cedazuridine drug combination 2Stem Cell Transplantation 2Maintenance 2Lymphatic Irradiation 2Leukapheresis 2Injections 2Granulocyte Colony-Stimulating Factor 2Drug Therapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Leukemia, Myeloid, Acute × Maintenance × Clear all
NCT07572929 2026-05-07

PREeMPT

Medical College of Wisconsin

Phase 2 Not yet recruiting
450 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT07407140 2026-03-25

VAG-3+7-G

Institute of Hematology & Blood Diseases Hospital, China

Phase 3 Not yet recruiting
300 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡